Advanced Enzyme Q2 FY27 consolidated PAT at Rs 51.20 cr, up 14% YoY
Advanced Enzyme Technologies’ Q2 FY27 consolidated income from operations rose to Rs 214.50 cr with net profit at Rs 51.20 cr versus Rs 44.70 cr in Q2 FY26.
Key takeaways
- Income from operations was Rs 214.50 cr in Q2 FY27 vs Rs 184.50 cr in Q2 FY26.
- Total expenses rose to Rs 153.30 cr in Q2 FY27 from Rs 134.50 cr in Q2 FY26.
- Net profit for the period was Rs 51.20 cr in Q2 FY27 vs Rs 44.70 cr in Q2 FY26.
- Earnings per share stood at Rs 4.33 in Q2 FY27 compared with Rs 3.87 in Q2 FY26.
Q2 FY27 · consolidated
| Metric | Sep 2026 | Sep 2025 | Change |
|---|---|---|---|
| Revenue | Rs 214.50 cr | Rs 184.50 cr | +16.3% |
| PAT | Rs 51.20 cr | Rs 44.70 cr | +14.5% |
As reported in the filing. Figures are transcribed, not computed.
What the numbers show
- Net margin was 23.87% of revenue, down 35 bps from 24.23%.
- Revenue rose 16.3% while total expenses rose 14.0%.
• Income from operations (revenue): Rs 214.50 cr in Q2 FY27 vs Rs 184.50 cr in Q2 FY26, as per the statement of financial results in the earnings presentation (Profit & Loss (Consolidated) – Q2 FY27 & H1 FY27).
• Total expenses: Rs 153.30 cr in Q2 FY27 vs Rs 134.50 cr in Q2 FY26.
• Profit from operations before other income, finance costs and exceptional item: Rs 61.20 cr in Q2 FY27 vs Rs 50.00 cr in Q2 FY26.
• Other income: Rs 8.70 cr in Q2 FY27 vs Rs 10.30 cr in Q2 FY26.
• Profit from ordinary activities before finance costs and exceptional item: Rs 69.90 cr in Q2 FY27 vs Rs 60.30 cr in Q2 FY26.
• Finance costs: Rs 1.20 cr in Q2 FY27 vs Rs 0.70 cr in Q2 FY26.
• Profit from ordinary activities before exceptional items and tax: Rs 68.80 cr in Q2 FY27 vs Rs 59.50 cr in Q2 FY26.
• Profit from ordinary activities before tax: Rs 68.80 cr in Q2 FY27 vs Rs 59.50 cr in Q2 FY26.
• Tax: Rs 17.60 cr in Q2 FY27 vs Rs 14.80 cr in Q2 FY26.
• Net profit for the period: Rs 51.20 cr in Q2 FY27 vs Rs 44.70 cr in Q2 FY26.
• Group consolidated net profit: Rs 51.20 cr in Q2 FY27 vs Rs 44.70 cr in Q2 FY26.
• Earnings per share: Rs 4.33 in Q2 FY27 vs Rs 3.87 in Q2 FY26.
In the consolidated statement of financial results for Q2 FY27, income from operations (revenue) is reported at Rs 214.50 cr, compared with Rs 184.50 cr in the corresponding quarter of the previous year. Total expenses increased to Rs 153.30 cr from Rs 134.50 cr over the same period. This resulted in profit from operations before other income, finance costs and exceptional item of Rs 61.20 cr in Q2 FY27, up from Rs 50.00 cr in Q2 FY26, as shown in the Profit & Loss (Consolidated) – Q2 FY27 & H1 FY27 table.
Other income for the quarter stood at Rs 8.70 cr versus Rs 10.30 cr a year earlier. Profit from ordinary activities before finance costs and exceptional item was Rs 69.90 cr in Q2 FY27 against Rs 60.30 cr in Q2 FY26. After finance costs of Rs 1.20 cr (Rs 0.70 cr in Q2 FY26), profit from ordinary activities before exceptional items and tax, which is also reported as profit from ordinary activities before tax, came in at Rs 68.80 cr versus Rs 59.50 cr in the year-ago quarter.
Tax expense rose to Rs 17.60 cr from Rs 14.80 cr. Net profit for the period is reported at Rs 51.20 cr, compared with Rs 44.70 cr in Q2 FY26. The table also presents group consolidated net profit at Rs 51.20 cr for Q2 FY27 versus Rs 44.70 cr a year earlier, and earnings per share at Rs 4.33 versus Rs 3.87 in the corresponding prior period.
Track Advanced Enzyme Technologies Ltd
Cruxal reads every Advanced Enzyme Technologies Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Get every filing that moves a stock
One email before the open, with the day's filings that actually shifted a price — the number, the source document and what the market did with it. Free, and you can unsubscribe from any issue.
Cruxal publishes market coverage for information only. Nothing here is investment advice.
